LY96 and cancer: We analyzed the correlation between LY96 expression and immunotherapeutic relevant signatures, and the results indicated that LY96 was positively correlated with immune checkpoint, CD8 T effector, antigen processing machinery, EMT2, and PanF TBR’s pathway in most cancers (Figure 10A).